MAX Aptekasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-07-01
Share capital
50,000.00 PLN
Registered address
Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland
Electronic delivery address
AE:PL-87107-41977-TFGDS-26

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$57,574

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 68 days for 2021). 3 of 6 audited by a statutory auditor.

  • 202513/07/2026
  • 202416/07/2025
  • 202319/07/2024
  • 202228/08/2023
  • 202121/09/2022
  • 202014/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 16%
Division · Retail trade1,344 / 9,929
Top 14%
City · Warszawa4,556 / 57,023
Top 8.0%
Voivodeship · Mazowieckie6,433 / 77,210
Top 8.3%
Country · Poland23,789 / 298,279
Top 8.0%

Results vs industry

Revenue
This companyUSD 7.63mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 452.35kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 7.09mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 4.91mMedianUSD 543.65kAverageUSD 1.76m

Public procurement

MAX Apteka is the contractor in one public sector contract, worth USD 246.82.

SubjectAmount
Supply of school first-aid kits
$246.82

National Health Fund (NFZ) contracts

MAX Apteka has been an NFZ healthcare provider since 2009. In 2026 it is performing 3 contracts with a total value of USD 297.14. All its contracts were worth USD 3.15k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesśląskie1USD 297.14
Other services provided in pharmaciesśląskie1USD 0.00
Other services provided in pharmacieswielkopolskie1USD 0.00

Authorized Representatives

Grzegorz Bajtałaage 51 – President of the Management Board

Manner of representation

If the management board is a multi-member management board, the submission of declarations of will on behalf of the company requires the joint action of two members of the management board or one member of the management board jointly with a commercial proxy. In the case of a one-person management board, the company is represented by the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
1,000$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-02-28.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 37,012

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,584
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$8,154
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,267

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2026-07-23PKD change
2023-12-04Address change
2023-12-04PKD change
2019-01-15Address change
2017-11-23Address change

FAQ

Last updated: 2026-10-07